Xenia Hotels & Resorts (XHR) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Q2 2024 net income was $15.3 million, up 11.2%–11.8% year-over-year, driven by an income tax benefit, lower depreciation, and reduced interest expense, partially offset by lower hotel operating income and higher G&A costs.
Adjusted EBITDAre for Q2 2024 was $68.4 million, down 8.4% year-over-year; Adjusted FFO per share was $0.52, up 10.6%.
Same-property RevPAR for Q2 2024 increased 1.8% to $185.69; excluding Hyatt Regency Scottsdale, RevPAR rose 5.0%.
Renovated and group-oriented hotels led RevPAR growth, while leisure demand softened as the quarter progressed.
The sale of Lorien Hotel & Spa for $30 million post-Q2 generated an estimated gain of $1.8 million.
Financial highlights
Q2 2024 revenues were $272.9 million, up 0.7% year-over-year; same-property hotel EBITDA was $73.4 million, down 7.5% with a margin decrease of 238 bps.
Q2 2024 occupancy was 71.0% (up 240 bps); ADR was $261.53 (down 1.7%).
Interest expense decreased 6.5% year-over-year to $20.2 million; cash and cash equivalents at June 30, 2024 were $143.6–$144 million.
Adjusted EBITDAre margin for Q2 2024 was 25.1%, down from 27.5% in Q2 2023.
Year-to-date same-property hotel EBITDA was $144.1 million, down 8.0%; margin was 26.7%.
Outlook and guidance
Full-year 2024 net income guidance: $18–$30 million; Adjusted EBITDAre: $243–$255 million; Adjusted FFO per share: $1.62–$1.74.
Full-year same-property RevPAR expected to increase 2.0–4.0% (2.75–4.75% excluding Hyatt Regency Scottsdale).
Adjusted EBITDAre guidance reduced by $5 million to $249 million, reflecting asset sale, renovation disruption, and lower RevPAR.
Margins expected to improve in H2, especially as Scottsdale ramps up post-renovation.
Guidance reflects macroeconomic uncertainty, expense pressures, and recent demand trends.
Latest events from Xenia Hotels & Resorts
- Double-digit earnings growth in 2025 with strong demand; 2026 outlook remains positive.XHR
Q4 202514 Mar 2026 - Q3 loss and margin pressure offset by occupancy gains, strong group demand, and project completions.XHR
Q3 202415 Jan 2026 - 2025 guidance projects 3.5–6.5% RevPAR growth and $244–$264M Adjusted EBITDAre.XHR
Q4 202423 Dec 2025 - Annual meeting covers director elections, pay, equity plan, auditor, and strong governance.XHR
Proxy Filing2 Dec 2025 - Board recommends approval of all proposals, including director elections and plan amendment.XHR
Proxy Filing2 Dec 2025 - Board seeks approval to expand equity awards, reinforcing pay-for-performance alignment.XHR
Proxy Filing2 Dec 2025 - Q1 2025 net income and RevPAR surged, but guidance was trimmed amid macro uncertainty.XHR
Q1 202528 Nov 2025 - Q2 net income soared over 259% on asset sale and group demand, with raised full-year guidance.XHR
Q2 202516 Nov 2025 - Year-to-date net income and EBITDAre rose despite a Q3 net loss and flat RevPAR.XHR
Q3 20252 Nov 2025